with/in/sight

three people conversing on a panel

The Koch Institute's with/in/sight public lecture series features the insights that emerge when powerful forces come together. We explore the intersections where science meets engineering, clinical practice meets urgent patient need, and entrepreneurial drive meets venture capital. We invite you to explore new vistas with us as we work together to bring cancer solutions within sight.

The with/in/sight series includes two types of events: SOLUTIONS programs that explore collaborative approaches to current challenges and trends in cancer diagnosis, monitoring and treatment; and SCIENCE programs that focus specifically on research happening in Koch Institute labs.

Upcoming Events

Anchor Management 

April 4, 2023

Learn about the convergent evolution of a KI bench-to-bedside collaboration that uses localized cytokine therapy to awaken a powerful immune response against solid tumors.

Algorithm & Views 

May 4, 2023

Two teams of investigators share their innovations using machine learning tools to improve lung cancer detection.

Past Events

Cancer Research Futures 

October 13, 2022

Meet the newest KI investigators and join the conversation about the interplay between discovery science and clinical practice.

How Are Cancer Researchers Fighting COVID-19? (Part III) 

March 29, 2022

The third in a series of COVID-specific with/in/sight events, this evening program will present updates from projects begun in spring 2020 to address urgent and pressing needs related to the pandemic.

Entrepreneurship and the KI 

November 1, 2021 

In this SOLUTIONS with/in/sight, Koch Institute investigators discuss why a startup was the right research move to turn innovation into impact.

Oxygenating the Pipeline 

October 6, 2021

This evening event profiles the bench to bedside progress of the Cima Lab's efforts targeting tumor oxygen levels as a vulnerability in cancer. 

A Foot in Both Worlds 

June 16, 2021

This roundtable discussion with past and present KI Clinical Investigators explores the relationship between laboratory benchwork and clinical translation and practice.

Unsung Research Heroes 

May 18, 2021

This evening webinar celebrates the scientists and engineers in the Robert A. Swanson (1969) Biotechnology Center, spotlighting their  role in three cancer-fighting innovations at the KI.  

 How Are Cancer Researchers Fighting COVID-19? (Part II) 

Part two of our virtual showcase of Koch Institute cancer researchers who have pivoted existing research to address biomedical challenges related to the COVID-19 pandemic.

How Are Cancer Researchers Fighting COVID-19? (Part I) 

This virtual event offers insight into the current research of MIT investigators who have taken existing projects and pivoted their technology and approaches to focus on urgent and pressing needs related to the COVID-19 crisis.

Pushing Boundaries, Breaking Barriers in Brain Cancer 

November 9, 2020

Members of the Koch Institute's Hammond and Yaffe Labs and the Clinical Investigator Program share how they are combining nanotechnology and novel drug combinations to treat glioblastoma. 

Catalytic Combinations for Prostate Cancer and Beyond 

December 10, 2019

Michael Yaffe and his clinical and biotech collaborators share how a new synergistic drug combination revived an all but forgotten drug class and shows great promise for combatting resistant tumors.

Using Artificial Intelligence to Make Mammography Smarter 

April 30, 2019

Regina Barzilay and Constance Lehman offer insight into the potential of new AI-driven solutions to transform mammography and shed light on novel solutions for biomedical challenges.